根据交易条款，交易完成后Hims需支付近2.4亿美元现金。Eucalyptus还可在未来18个月内获得递延业绩 对价，并有望在2029年初前根据财务目标完成情况收取额外款项。 Hims可选择以现金或股票形式支付大部分递延及业绩对价。 智通财经APP获悉，Hims & Hers Health(HIMS.US)宣布将以现金加股票的方式收购澳大利亚数字健康服 务商Eucalyptus，交易价值最高可达11.5亿美元。受此消息提振，该公司股价周四美股盘前上涨约7%。 总部位于悉尼的Eucalyptus年营收规模超4.5亿美元，是澳大利亚规模最大的数字健康服务商。Hims预 计，此次收购将助力其拓展澳大利亚与日本市场，并进一步扩大在英国、德国和加拿大的业务布局。 据了解，总部位于美国加州旧金山的Hims主营减重药物复方制剂销售，预计本次交易资金主要来自公 司现有现金及美国业务的运营现金流。该交易预计于2026年年中完成。 ...

Group 1: Company Overview - CIMG Inc. specializes in digital health and sales development, utilizing technologies and marketing networks to enhance business partners' sales growth and commercial value [1][4] - The company has a cryptocurrency-focused strategy, leveraging AI and cryptocurrencies to drive business growth and enhance brand management value [4] Group 2: Product Highlights - CIMG's premium sauce-flavor baijiu brand, Huo Mao, received the "2025 China New Consumption Craftsmanship Heritage Award" from iiMedia Research, highlighting its recognition in the market [1] - The Huo Mao baijiu series combines ancient brewing techniques with modern technology, featuring a time-intensive production process and the use of high-quality dendrobium from Mount Huo, which enhances its flavor profile [2] Group 3: Leadership Vision - The CEO of CIMG, Alice Wang, emphasizes the company's commitment to innovation and the preservation of intangible cultural heritage, aiming to expand into health and wellness products that reflect China's traditional wellness culture [3]

Core Viewpoint - AMTD Group is injecting its beneficial holdings of 2,034,321 shares of Series F Preferred Shares of We Doctor Holdings Limited into AMTD Digital, highlighting a strategic move in the digital health service market [1] Group 1: Company Actions - AMTD Group will transfer its beneficial holdings of 2,034,321 shares of Series F Preferred Shares of We Doctor Holdings Limited into AMTD Digital [1] - This action signifies AMTD Group's commitment to enhancing its position in the digital health sector [1] Group 2: Industry Context - We Doctor Holdings Limited is recognized as a pioneer in AI-enabled healthcare solutions in China [1] - In 2024, We Doctor ranked No. 1 in revenue within the digital health service market, indicating its leading position in the industry [1]